EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy

Fang Li iD, Biao Song, Wei-Feng Zhou, Li-Jin Chu

Viral Immunology · 2023

DOI: 10.1089/vim.2023.0077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viral Immunology, 2023. Verfasst von Fang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Anhui Medical College, Hefei, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Toll-Like Receptor 8. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The innate immune system recognizes conserved features of viral and microbial pathogens through pattern recognition receptors (PRRs). Toll-like receptors (TLRs) are one type of PRR used by the innate immune system to mediate the secretion of proinflammatory cytokines and promote innate and adaptive immune responses. TLR family members TLR7 and TLR8 (referred to as TLR7/8 from herein) are endosomal transmembrane receptors that recognize purine-rich single-stranded RNA (ssRNA) and bacterial DNA, eliciting an immunologic reaction to pathogens. TLR7/8 were discovered to mediate the secretion of proinflammatory cytokines by activating immune cells. In addition, accumulating evidence has indicated that TLR7/8 may be closely related to numerous immune-mediated disorders, specifically several types of cancer, autoimmune disease, and viral disease. TLR7/8 agonists and antagonists, which are used as drugs or adjuvants, have been identified in preclinical studies and clinical trials as promising immune stimulators for the immunotherapy of these immune-mediated disorders. These results provided reasoning to further explore immunotherapy for the treatment of immune-mediated disorders. Nevertheless, numerous needs remain unmet, and the therapeutic effects of TLR7/8 agonists and antagonists are poor and exert strong immune-related toxicities. The present review aimed to provide an overview of the TLR family members, particularly TLR7/8, and address the underlying molecular mechanisms and clinical implications of TLR7/8 in immune-mediated disorders. The aim of the work is to discuss the underlying molecular mechanisms and clinical implications of TLR7/8 in immune-mediated disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Toll-Like Receptor 8Toll-Like ReceptorsCytokinesAdjuvants, ImmunologicImmunotherapyImmunity

Stichwörter der Autor:innen

TLR7/8immune-mediated disordersimmunological reactionimmunotherapymolecular mechanisms

Substanzen

Toll-Like Receptor 7Toll-Like Receptor 8Toll-Like ReceptorsCytokinesAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Clinical Medicine, Anhui Medical College, Hefei, China.
  • Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID-Profile: Fang Li

Zitieren

APA

Li, F., Song, B., Zhou, W. F., & Chu, L. J. (2023). Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy. Viral Immunology. https://doi.org/10.1089/vim.2023.0077

Vancouver

Li F, Song B, Zhou WF, Chu LJ. Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy. Viral Immunology. 2023. doi:10.1089/vim.2023.0077

BibTeX
@article{Li2023,
  author = {Li, Fang and Song, Biao and Zhou, Wei-Feng and Chu, Li-Jin},
  title = {Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy},
  journal = {Viral Immunology},
  year = {2023},
  doi = {10.1089/vim.2023.0077}
}
Kostenlos starten →